CE-22-010 Supporting Treatment Access and Recovery through Linkage and Support (STAR-LS)
CE-22-010 Supporting Treatment Access and Recovery through Linkage and Support (STAR-LS)
批准号:
10705205
负责人:
Ayorkor Gaba
金额:
$74.94万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-09-30 至 2025-09-29
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY / ABSTRACT
Addiction is a growing public health problem in the United States (U.S.), with nearly 21 million Americans meeting
criteria for substance use disorder (SUD), 1.6 million meeting criteria for opioid use disorder (OUD), and opioid-
related overdoses have increased by 50% over the past 5 years. Among people with SUD, 49% have comorbid
mental health disorders (COD). Individuals with COD are vulnerable to substance use relapses, mental illness
exacerbations, overdoses, homelessness, and criminal justice involvement. However, despite the high rates of
morbidity, mortality, and broad social determinant of health needs among people with COD, only 8% of
individuals in the U.S. received treatment for both mental illness and SUD. Among those with a COD receiving
treatment, 6-month engagement rates are as low as 16% for psychosocial treatments, and 90% of individuals
leaving treatment will relapse within 12 weeks. Massachusetts is also hard hit, with a 16% higher SUD prevalence
compared to the U.S., and Worcester, the second largest city in Massachusetts, is disproportionately affected
by SUD, having one of the highest overdose rates in the state and is ranked 2nd on the CDC social vulnerability
index. These findings highlight the need to improve treatment access and engagement to support recovery in
Worcester, Massachusetts. Both linkage and multicomponent wraparound models have gained popularity as a
solution to increase treatment access and engagement. Maintaining Independence and Sobriety through
Systems Integration, Outreach and Networking (MISSION) is a hybrid multicomponent linkage and treatment
approach, providing assertive outreach linkage support combined with psychosocial treatment, delivered by a
cross disciplinary team. MISSION is aligned with the Social Ecological Model (SEM) to address multilevel client
needs via 3 evidence-based practices. They include 1) Critical Time Intervention (CTI), a time-limited form of
assertive community treatment; 2) Dual Recovery Therapy (DRT), which is integrated group therapy for COD;
and 3) Peer Support (PS), offering support for people in recovery by people in recovery. In response to RFA-
CE-22-010, the proposed 3-year Hybrid Type I study, “Supporting Treatment Access and Recovery through
Linkage and Support (STAR-LS),” will recruit and randomize 208 patients with COD in Worcester, MA in the
Hub, a program run by the Worcester Health and Human Services to one of the following conditions: 1) MISSION;
or 2) Peer Support (linkage only). There are three specific aims: Aim 1: To evaluate the effectiveness of
MISSION or compared to Peer Support to improve engagement, substance use and mental health symptoms.
Aim 2: To examine mechanisms of action of the interventions. Aim 3: To conduct a sequential mixed methods
process evaluation to inform sustainability and future implementation. This proposal is aligned with CDC’s
Strategic Priority Areas and Health People 2030 Core Objectives as it intends to improve behavioral health
outcomes strengthen and sustain the recovery ecosystem for people with COD.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Supporting Treatment Access and Recovery through Linkage and Support (STAR-LS)
-
批准号:10591733
-
项目类别:
-
资助金额:$74.74万
-
财政年份:2022
-
负责人:Ayorkor Gaba
-
依托单位:
国内基金
海外基金
登录
查看更多内容
基于 ANKRD22 介导的脂代谢重编程激活Notch4/HES1 通路促进巨噬细胞获得免疫抑制表型机制研究
-
批准号:ZCLMS26H1601
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:肖于飞
-
依托单位:
基于“Akkermansia muciniphila—ILC3/IL-22轴”探究竹节参总皂苷改善高脂饮食诱导的脂质代谢紊乱
-
批准号:JCZRLH202600409
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
SLC22A4作为冠心病新型炎症标志物的功能与机制研究
-
批准号:2026JJ81785
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:刘斌
-
依托单位:
miR-22通过调控巨噬细胞功能抑制免疫力的分子机制研究
-
批准号:2026JJ81780
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:邢佼涛
-
依托单位:
CD22抑制TFEB核转位介导阿尔茨海默病小胶质细胞功能障碍的分子机制研究
-
批准号:2026JJ50272
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:李建
-
依托单位:
KAT2A介导的USP22琥珀酰化通过稳定SOX4促进结直肠癌进展的分子机制研究
-
批准号:2026JJ82028
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:程发辉
-
依托单位:
USP22通过去泛素稳定GRB7促进结直肠癌发展的机制研究
-
批准号:2026JJ60159
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:鞠昭
-
依托单位:
ANKRD22调控PI3K/AKT/mTOR信号抑制自噬促进宫颈癌增殖和转移的机制研究
-
批准号:JCZRLH202601139
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
PRSS22通过调控PPM1A激活NF-κB通路促进肝癌恶性进展的机制研究
-
批准号:2026JJ82630
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:许晨
-
依托单位:
补阳还五汤通过调控USP22–Beclin1信号轴干预自噬依赖性铁死亡缓解脑缺血再灌注损伤的机制研究
-
批准号:2026JJ80615
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:郑春茂
-
依托单位: